Integra Lifesciences Holdings CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Integra LifeSciences Holdings Corporation announced its 2026 Annual Meeting of Stockholders, set for May 7, 2026, to elect directors, ratify auditors, and approve executive compensation and an equity incentive plan amendment.
NASDAQ
Integra LifeSciences' proxy statement outlines the company's 2024 performance, strategic initiatives, and executive compensation, while addressing operational challenges and future growth plans.
NASDAQ
Integra LifeSciences is asking stockholders to approve amendments to its corporate charter and equity incentive plan at the upcoming annual meeting.